Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2026-06-30 16:20:56 ET · period of report 2026-06-29 · accession 0001193125-26-290586 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 16:20 | 2026-06-29 | BNTC | BUCHI J KEVIN | Dir | G - Gift | $0.00 | -51.8K | 52.1K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | G | D | 51,813 | $0.00 | 52,097 | D | — | — | (F1) The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code. |